The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis

Journal of Neurosciences in Rural Practice

Volumn 3, Issue 3, 2012, Pages 294-298

  Jafarirad, Sima ^a   Siassi, Fereydoon ^a   Harirchian, Mohammad Hossein ^b   Sahraian, Mohammad Ali ^c   Eshraghian, Mohammad Reza ^a   Shokri, Fazel ^a   Amani, Reza ^d   Bitarafan, Sama ^a   Mozafari, Sabah ^e   Saboor Yaraghi, Aliakbar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Cell proliferation; Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Vitamin A

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PHYTOHEMAGGLUTININ; PLACEBO; RETINOL PALMITATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOUBLE BLIND PROCEDURE; FEMALE; FETAL CALF SERUM; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VITAMIN SUPPLEMENTATION;

EID: 84870221789     PISSN: 09763147     EISSN: 09763155     Source Type: Journal    
DOI: 10.4103/0976-3147.102609     Document Type: Article

References (26)

1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747. (Pubitemid 40563183)
2. Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002;3:291-301. (Pubitemid 135706608)
3. Hallin E, Mellegrd J, Vrethem M, Ernerudh J, Ekerfelt C. In vitro Th2 deviation of myelin-specific peripheral blood lymphocytes from patients with multiple sclerosis. J Neuroimmunol 2006;171:156-62. (Pubitemid 41832286)
4. Xiao BG, Link H. Antigen-specific T cells in autoimmune diseases with a focus on multiple sclerosis and experimental allergic encephalomyelitis. Cell Mol Life Sci 1999;56:5-21. (Pubitemid 29471921)
5. Kim CH. Regulation of FoxP3+ regulatory T cells and Th17 cells by retinoids. Clin Dev Immunol 2008;2008:1-12.
6. Lovett-Racke AE, Racke MK. Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells. Cell Immunol 2002;215:54-60.
7. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990;8:579-621. (Pubitemid 20135640)
8. Miller SD, Karpus WJ. The immunopathogenesis and regulation of T-cell-mediated demyelinating disease. Immunol Today 1994;15:356-61. (Pubitemid 24246908)
9. Mendel I, Kerlero de Rosbo N, Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 1995;25:1951-9.
10. Miller SD, McRae BL, Vanderlugt CL, Nikcevich KM, Pope JG, Pope L, et al. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating disease. Immunol Rev 1995;144:225-44.
11. Mendel I, Kerlero de Rosbo N, Ben-Nun A. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: Diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2 b mice. Eur J Immunol 1996;26:2470-9. (Pubitemid 26340952)
12. Samoilova EB, Horton JL, Chen Y. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: Roles of interleukin-10 in disease progression and recovery. Cell Immunol 1998;188:118-24. (Pubitemid 28493564)
13. Engedal N, Gjevik T, Blomhoff R, Blomhoff HK. All-trans retinoic acid stimulates IL-2-mediated proliferation of human T lymphocytes: Early induction of cyclin D3. J Immunol 2006;177:2851-61. (Pubitemid 44277800)
14. Allen LH, Haskell M. Estimating the potential for vitamin A toxicity in women and young children. J Nutr 2002;132:2907S-19S. (Pubitemid 35013216)
15. Kerlero de Rosbo N, Milo R, Lees MB, Burger D, Bernard CC, Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 1993;92:2602-8. (Pubitemid 24006523)
16. Duester G. Families of retinoid dehydrogenases regulating vitamin A function: Production of visual pigment and retinoic acid. Eur J Biochem 2000;267:4315-24. (Pubitemid 30461062)
17. Duester G, Mic FA, Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem Biol Interact 2003;143-4:201-10. (Pubitemid 36246442)
18. Villamor E, Fawzi WW. Effects of vitamin A supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev 2005;18:446-64. (Pubitemid 40995111)
19. Firpo EJ, Koff A, Solomon MJ, Roberts JM. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 1994;14:4889-901. (Pubitemid 24196838)
20. Lea NC, Orr SJ, Stoeber K, Williams GH, Lam EW, Ibrahim MA, et al. Commitment point during G 0 G 1 that controls entry into the cell cycle. Mol Cell Biol 2003;23:2351-61. (Pubitemid 36351018)
21. Nelson BH, Willerford DM. Biology of the interleukin-2 receptor. Adv Immunol 1998;70:1-81. (Pubitemid 128678836)
22. Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 1995;54:450-8.
23. Dawson HD, Collins G, Pyle R, Key M, Weeraratna A, Deep-Dixit V, et al. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol 2006;7:27.
24. Cippitelli M, Ye J, Viggiano V, Sica A, Ghosh P, Gulino A, et al. Retinoic acid-induced transcriptional modulation of the human interferon- promoter. J Biol Chem 1996;271:26783-93. (Pubitemid 26359088)
25. Massacesi L, Castigli E, Vergelli M, Olivotto J, Abbamondi AL, Sarlo F, et al. Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. J Clin Invest 1991;88:1331-7.
26. Qu ZX, Dayal A, Jensen MA, Arnason BG. All-trans retinoic acid potentiates the ability of interferon Beta-1b to augment suppressor cell function in multiple sclerosis. Arch Neurol 1998;55:315-21. (Pubitemid 28146196)